Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family.
about
Activation of signalling by the activin receptor complexInhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanismGenomic structure and cloned cDNAs predict that four variants in the kinase domain of serine/threonine kinase receptors arise by alternative splicing and poly(A) additionA novel ability of Smad3 to regulate proteasomal degradation of a Cas family member HEF1Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activinActivin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesisThe Discovery and Early Days of TGF-β: A Historical PerspectiveAnalysis of the native murine bone morphogenetic protein serine threonine kinase type I receptor (ALK-3)Ontogeny and localization of TGF-beta type I receptor expression during lung developmentCloning and characterization of a transmembrane serine kinase that acts as an activin type I receptorBMP type I receptor ALK2 is essential for proper patterning at late gastrulation during mouse embryogenesisThe type I activin receptor ActRIB is required for egg cylinder organization and gastrulation in the mouseDevelopment of TGF-beta resistance during malignant progression.Inhibin at 90: from discovery to clinical application, a historical reviewMüllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumorsStromal-to-epithelial transition during postpartum endometrial regeneration.Mullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines.Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor beta receptor kinases.The transforming growth factor beta family and induction of the vertebrate mesoderm: bone morphogenetic proteins are ventral inducers.The types II and III transforming growth factor-beta receptors form homo-oligomers.TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors.Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.Down-regulation of TGF-beta receptors in human colorectal cancer: implications for cancer development.Development of an efficiently cleaved, bioactive, highly pure FLAG-tagged recombinant human Mullerian Inhibiting Substance.Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex.Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells.Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian CancerCloning, characterization, and expression of the transforming growth factor-beta type I receptor promoter in fetal rat bone cells.Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGFbeta3): from laboratory discovery to clinical pharmaceutical.Avotermin: a novel antiscarring agent.Ligand-independent activation of transforming growth factor (TGF) beta signaling pathways by heteromeric cytoplasmic domains of TGF-beta receptors.MFP1, a novel plant filament-like protein with affinity for matrix attachment region DNA.A chimeric serine/threonine kinase receptor system reveals the potential of multiple type II receptors to cooperate with transforming growth factor-beta type I receptor.Molecular analysis of TGF beta signal transduction. Dominant-inhibitory mutations of the type II and type I TGF beta receptor.Transcriptional activation of the type II transforming growth factor-beta receptor gene upon differentiation of embryonal carcinoma cells.Signal transduction and TGF-beta superfamily receptors.Reconstitution of a pentameric complex of dimeric transforming growth factor beta ligand and a type I, II, III receptor in baculoviral-infected insect cells.Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors.Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells.Inactive type II and type I receptors for TGF beta are dominant inhibitors of TGF beta-dependent transcription.
P2860
Q24308084-EDEFE5C3-22B6-410A-A9E9-BC264A587F8AQ24317361-ED946993-A83E-484A-88A7-187E3FB1C0D0Q24564207-D86BCE7A-F6DD-4F82-8C5F-5DADDBD6D11BQ24595443-5191AAE4-F93B-498C-AF66-29DFBB5F4850Q24612297-79CA5FF7-D9CE-46EA-BE62-7C1FA6DE2D83Q24677057-92DEF4B4-E3FD-4D47-BB74-E456C374BE0CQ28276556-6E9709E0-F8F1-404A-AE65-16A7C994EFB8Q28284898-E8576ADB-72D3-42B6-B86E-C8DDC180A23DQ28573806-095A76C7-96D8-4067-B138-77CA31C1D563Q28580056-777090B9-7B8D-43DE-8EAA-958F8E4C0242Q28586330-B1E91D69-A53D-4D62-AD90-9C7F0F2687AEQ28586850-5BC3EF0D-488F-4CE9-967E-32379DFD3094Q33540025-85A6B1A6-0335-4591-B73C-CCF7F5CC3C10Q34204531-1E72E8EF-365A-4A06-AD49-FF35E0320655Q34246272-B5246213-D983-48B4-AB3B-3F089E512E0CQ34411987-9D134DA3-3FAC-4A16-B7D5-B001A465B747Q34434627-DBEC3269-4C79-47A0-90AC-497F5E54CE4AQ34632777-179E7A7B-3B99-495E-8561-3AFE57B55658Q35843521-F226C9BC-3E3C-4F35-AA56-9CF34A680F7DQ36234419-C7301A59-CADE-40A8-A38C-54E2D21C545BQ36235100-B43511B2-EE01-43FC-9FB9-8D030D888317Q36235769-F8DBC8E2-25F6-4A67-BF95-8A0614057829Q36620077-136ABBE6-372E-4940-98C3-1BFC2C0DF9C7Q36637142-F159413F-C584-4A02-9830-AA8F3E283BE8Q36645287-022CDD25-C333-43AA-AB2E-4077766E2D8EQ36665327-8EEFD3E9-50C9-4F15-870D-C0FFC4E9990FQ36743937-08B7B40F-428B-4CB5-A93A-121FC88F9FB8Q36839904-79290C03-4207-420F-8837-A496B3B99F43Q37222825-2AEB623E-1EEA-4216-BE4F-822F21444679Q37256097-F8D24B0F-4009-49E7-9AB8-F60F9C161DFDQ38357458-D2ABBA2F-D3DA-402E-80F0-A9EA1A8799C1Q38503777-80F40BAD-42C3-4E34-A614-6667EFEB3150Q40243393-C5066114-8B12-4464-8531-866687121D0AQ40528472-9DA27CDF-BAF0-4B8B-A8B5-37F3271E76D4Q41018727-3BE43824-C871-4254-8BDA-00FFC98B830AQ41179943-C65883A6-E2B0-46AB-9F23-17C48FD56E0BQ41193401-065216CB-94C5-4DCE-983F-639A346974A4Q41282869-1974D468-0459-47B8-8BB9-4793AD7C3ACCQ41331286-3019EA0B-1363-48C6-B19C-BA7BD76FEBB5Q41350985-5C0827DD-EAC6-4CEA-A207-D397978455AC
P2860
Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Developmental expression of fo ...... -beta type II receptor family.
@ast
Developmental expression of fo ...... -beta type II receptor family.
@en
type
label
Developmental expression of fo ...... -beta type II receptor family.
@ast
Developmental expression of fo ...... -beta type II receptor family.
@en
prefLabel
Developmental expression of fo ...... -beta type II receptor family.
@ast
Developmental expression of fo ...... -beta type II receptor family.
@en
P2093
P2860
P356
P1476
Developmental expression of fo ...... -beta type II receptor family.
@en
P2093
P2860
P304
P356
10.1002/AJA.1001960207
P577
1993-02-01T00:00:00Z